Back to Search
Start Over
P-347 A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1.
- Source :
-
Annals of Oncology . 2020 Supplement 3, Vol. 31, pS202-S203. 2p. - Publication Year :
- 2020
- Subjects :
- *HEPATOCELLULAR carcinoma
*CHEMOEMBOLIZATION
*ANTINEOPLASTIC agents
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152684331
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.04.429